Clinical Trial Update: A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer [Phase 1]

View source ↗

Summary

This document summarizes the completed Phase I trial evaluating the combination of capecitabine, gemcitabine, and erlotinib in patients with advanced pancreatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• ERLOTINIB (Erlotinib)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Metastatic Pancreatic Carcinoma | Phase 1 | Status: COMPLETED